AvKARE recalls
14 notices naming AvKARE as the recalling firm, since December 11, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
AvKARE: Fludrocortisone Acetate Tablets
Hazard (FDA): Failed Impurities/Degradation Specifications
FDAMedicines
Dissolution
AvKARE: Amantadine HCl
Hazard (FDA): Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.
FDAMedicines
Dissolution
AvKARE: Rosuvastatin Tablets
Hazard (FDA): Out of specification for dissolution.
FDAMedicines
AvKARE: Norgestimate and Ethinyl Estradiol Tablets
Hazard (FDA): Failed Content Uniformity Specifications
FDAMedicines
AvKARE: chloroproMAZINE Hydrochloride Tablets and 1 more
Hazard (FDA): Presence of a foreign substance.
FDAMedicines
AvKARE: Pitavastatin Tablets and 1 more
Hazard (FDA): Failed Impurity/Degradation Specifications
FDAMedicines
AvKARE: Celecoxib Capsules
Hazard (FDA): Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsules
FDAMedicines
Dissolution
AvKARE: Chlorthalidone Tablets
Hazard (FDA): Failed Dissolution Specifications
FDAMedicines
AvKARE: Silodosin Capsules
Hazard (FDA): Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)
FDAMedicines
Dissolution
AvKARE: Irbesartan Tablets USP
Hazard (FDA): Out of Specification for Dissolution
FDAMedicines
AvKARE: Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing Lubricant Eye Drops and 1 more
Hazard (FDA): LABELING: LABEL MIX-UP
FDAMedicines
Dissolution
AvKARE: Nitrofurantoin Capsules
Hazard (FDA): Failed Dissolution Specifications
FDAMedicines
AvKARE: Cinacalcet Tablets and 2 more
Hazard (FDA): CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.
FDAMedicines